Skip to main content
. 2022 Nov 11;13:1058819. doi: 10.3389/fimmu.2022.1058819

Figure 9.

Figure 9

Comparisons of number of deaths per 100,000 patients with metastatic non-small cell lung cancer between the pre-immunotherapy and the immunotherapy eras grouped by treatments.